Bortezomib
bortezomib
post date: dec 08,2021 expiry date: dec 08,2022 detailed description: cas no. :179324-69-7 name:bortezomibcas no.:179324-69-7m.f.:c19h25bn4o4m.w.:384.24assay: min.99% cas registry number: 179324-69-7 synonyms: ;velcade;dpba;[(1r)-3-methyl-1-[[(2s)-1-oxo-3-phenyl-2-[(pyrazinylcarbonyl)amino]propyl]amino]butyl]-boronic acid;velcade(bortezomib);boronic acid, b-[(1r)-3-methyl-1-[[(2s)-1-oxo-3-phenyl-2-[(2-pyrazinylcarbonyl)amino]propyl]amino]butyl]-;bortezomib for research;n-[(1s)-1-(dihydroxyboranyl)-3-methylbutyl]-nalpha-(pyrazin-2-ylcarbonyl)-d-phenylalaninamide;n-[(1r)-1-(dihydroxyboranyl)-3-methylbutyl]-nalpha-(pyrazin-2-ylcarbonyl)-l-phenylalaninamide;bortizomib; molecular formula: c19h25bn4o4 molecular weight: 384.2372 molecular structure:
bortezomib
post date: dec 07,2021 expiry date: jun 05,2022 detailed description: cas no. :179324-69-7 bortezomib179324-69-7 cas registry number: 179324-69-7 synonyms: ;velcade;dpba;[(1r)-3-methyl-1-[[(2s)-1-oxo-3-phenyl-2-[(pyrazinylcarbonyl)amino]propyl]amino]butyl]-boronic acid;velcade(bortezomib);boronic acid, b-[(1r)-3-methyl-1-[[(2s)-1-oxo-3-phenyl-2-[(2-pyrazinylcarbonyl)amino]propyl]amino]butyl]-;bortezomib for research;n-[(1s)-1-(dihydroxyboranyl)-3-methylbutyl]-nalpha-(pyrazin-2-ylcarbonyl)-d-phenylalaninamide;n-[(1r)-1-(dihydroxyboranyl)-3-methylbutyl]-nalpha-(pyrazin-2-ylcarbonyl)-l-phenylalaninamide;bortizomib; molecular formula: c19h25bn4o4 molecular weight: 384.2372 molecular structure:
bortezomib
post date: dec 07,2021 expiry date: jun 05,2022 detailed description: cas no. :179324-69-7 cas registry number: 179324-69-7 synonyms: ;velcade;dpba;[(1r)-3-methyl-1-[[(2s)-1-oxo-3-phenyl-2-[(pyrazinylcarbonyl)amino]propyl]amino]butyl]-boronic acid;velcade(bortezomib);boronic acid, b-[(1r)-3-methyl-1-[[(2s)-1-oxo-3-phenyl-2-[(2-pyrazinylcarbonyl)amino]propyl]amino]butyl]-;bortezomib for research;n-[(1s)-1-(dihydroxyboranyl)-3-methylbutyl]-nalpha-(pyrazin-2-ylcarbonyl)-d-phenylalaninamide;n-[(1r)-1-(dihydroxyboranyl)-3-methylbutyl]-nalpha-(pyrazin-2-ylcarbonyl)-l-phenylalaninamide;bortizomib; molecular formula: c19h25bn4o4 molecular weight: 384.2372 molecular structure:

